PEAK6’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.62M Sell
61,400
-9,800
-14% -$532K 0.01% 1168
2026
Q1
$4.47M Sell
71,200
-31,700
-31% -$2.54M 0.01% 954
2025
Q4
$9.81M Buy
102,900
+8,100
+9% +$794K 0.02% 656
2025
Q3
$9.26M Buy
94,800
+11,300
+14% +$1.17M 0.01% 726
2025
Q2
$8.97M Sell
83,500
-20,400
-20% -$2.06M 0.02% 675
2025
Q1
$10.5M Buy
103,900
+57,800
+125% +$5.82M 0.02% 579
2024
Q4
$4.12M Buy
+46,100
New +$4.06M 0.01% 1017

Other funds holding BSX

PEAK6's BSX Position: Q2 2026 in Review

PEAK6 increased its Boston Scientific (BSX) stake by 2,461% in Q2 2026, buying an estimated $35.7M and bringing the position to 683,808 shares worth $29.2M. The position accounts for 0.06% of the portfolio, ranked #258.

PEAK6 first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • PEAK6 held 683,808 shares of Boston Scientific worth $29.2M as of Q2 2026.
  • PEAK6 bought 657,108 Boston Scientific shares in Q2 2026, an estimated $35.7M.
  • Boston Scientific made up 0.06% of PEAK6's portfolio in Q2 2026, its #258 holding.
  • PEAK6 first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.